These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31328486)

  • 1. [A new bioinformatics approach for prediction of potential tumor neoantigens based on the cancer genome atlas dataset].
    Huang C; Ma J; Wu C; Zhu Y
    Sheng Wu Gong Cheng Xue Bao; 2019 Jul; 35(7):1295-1306. PubMed ID: 31328486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TSNAdb: A Database for Tumor-specific Neoantigens from Immunogenomics Data Analysis.
    Wu J; Zhao W; Zhou B; Su Z; Gu X; Zhou Z; Chen S
    Genomics Proteomics Bioinformatics; 2018 Aug; 16(4):276-282. PubMed ID: 30223042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population-level distribution and putative immunogenicity of cancer neoepitopes.
    Wood MA; Paralkar M; Paralkar MP; Nguyen A; Struck AJ; Ellrott K; Margolin A; Nellore A; Thompson RF
    BMC Cancer; 2018 Apr; 18(1):414. PubMed ID: 29653567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic analysis of 63,220 tumors reveals insights into tumor uniqueness and targeted cancer immunotherapy strategies.
    Hartmaier RJ; Charo J; Fabrizio D; Goldberg ME; Albacker LA; Pao W; Chmielecki J
    Genome Med; 2017 Feb; 9(1):16. PubMed ID: 28231819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioinformatic methods for cancer neoantigen prediction.
    Boegel S; Castle JC; Kodysh J; O'Donnell T; Rubinsteyn A
    Prog Mol Biol Transl Sci; 2019; 164():25-60. PubMed ID: 31383407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analysis of neoantigens derived from structural variation across whole genomes from 2528 tumors.
    Shi Y; Jing B; Xi R
    Genome Biol; 2023 Jul; 24(1):169. PubMed ID: 37461029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic Analysis of Tumor Microenvironment Immune Types across 14 Solid Cancer Types: Immunotherapeutic Implications.
    Chen YP; Zhang Y; Lv JW; Li YQ; Wang YQ; He QM; Yang XJ; Sun Y; Mao YP; Yun JP; Liu N; Ma J
    Theranostics; 2017; 7(14):3585-3594. PubMed ID: 28912897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The neoepitope landscape of breast cancer: implications for immunotherapy.
    Narang P; Chen M; Sharma AA; Anderson KS; Wilson MA
    BMC Cancer; 2019 Mar; 19(1):200. PubMed ID: 30832597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High Somatic Mutation and Neoantigen Burden Do Not Correlate with Decreased Progression-Free Survival in HCC Patients not Undergoing Immunotherapy.
    Mauriello A; Zeuli R; Cavalluzzo B; Petrizzo A; Tornesello ML; Buonaguro FM; Ceccarelli M; Tagliamonte M; Buonaguro L
    Cancers (Basel); 2019 Nov; 11(12):. PubMed ID: 31756926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NEPdb: A Database of T-Cell Experimentally-Validated Neoantigens and Pan-Cancer Predicted Neoepitopes for Cancer Immunotherapy.
    Xia J; Bai P; Fan W; Li Q; Li Y; Wang D; Yin L; Zhou Y
    Front Immunol; 2021; 12():644637. PubMed ID: 33927717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoantigen Targeting-Dawn of a New Era in Cancer Immunotherapy?
    Wirth TC; Kühnel F
    Front Immunol; 2017; 8():1848. PubMed ID: 29312332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. dbPepNeo: a manually curated database for human tumor neoantigen peptides.
    Tan X; Li D; Huang P; Jian X; Wan H; Wang G; Li Y; Ouyang J; Lin Y; Xie L
    Database (Oxford); 2020 Jan; 2020():. PubMed ID: 32090262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel neoantigen discovery approach based on chromatin high order conformation.
    Shi Y; Zhang M; Meng L; Su X; Shang X; Guo Z; Li Q; Lin M; Zou X; Luo Q; Yu Y; Wu Y; Da L; Cai TW; He G; Han ZG
    BMC Med Genomics; 2020 Aug; 13(Suppl 6):62. PubMed ID: 32854726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Harnessing gene fusion-derived neoantigens for 'cold' breast and prostate tumor immunotherapy.
    Velaga R; Koo KM; Mainwaring PN
    Immunotherapy; 2022 Oct; 14(14):1165-1179. PubMed ID: 36043380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Untranslated regions (UTRs) are a potential novel source of neoantigens for personalised immunotherapy.
    Sng CCT; Kallor AA; Simpson BS; Bedran G; Alfaro J; Litchfield K
    Front Immunol; 2024; 15():1347542. PubMed ID: 38558815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GNIFdb: a neoantigen intrinsic feature database for glioma.
    Li W; Sun T; Li M; He Y; Li L; Wang L; Wang H; Li J; Wen H; Liu Y; Chen Y; Fan Y; Xin B; Zhang J
    Database (Oxford); 2022 Feb; 2022():. PubMed ID: 35150127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Comprehensive Survey of Genomic Alterations in Gastric Cancer Reveals Recurrent Neoantigens as Potential Therapeutic Targets.
    Chen C; Zhou Q; Wu R; Li B; Chen Q; Zhang X; Shi C
    Biomed Res Int; 2019; 2019():2183510. PubMed ID: 31781598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MHC class II restricted neoantigen: A promising target in tumor immunotherapy.
    Sun Z; Chen F; Meng F; Wei J; Liu B
    Cancer Lett; 2017 Apr; 392():17-25. PubMed ID: 28104443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying neoantigens for use in immunotherapy.
    Hutchison S; Pritchard AL
    Mamm Genome; 2018 Dec; 29(11-12):714-730. PubMed ID: 30167844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neopepsee: accurate genome-level prediction of neoantigens by harnessing sequence and amino acid immunogenicity information.
    Kim S; Kim HS; Kim E; Lee MG; Shin EC; Paik S; Kim S
    Ann Oncol; 2018 Apr; 29(4):1030-1036. PubMed ID: 29360924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.